Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.180
+0.050 (1.60%)
Nov 21, 2024, 4:00 PM EST - Market closed
Zentalis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | -179.28 | -292.19 | -236.81 | -158.73 | -117.84 | -45.66 | Upgrade
|
| Depreciation & Amortization | 1.31 | 1.39 | 1.43 | 0.54 | 0.16 | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.32 | 0.41 | 0.06 | -49.92 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 20 | - | 8.8 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -19.08 | -13.16 | -3.73 | 0.91 | 0.56 | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | 16.01 | 16.28 | 1.83 | - | - | Upgrade
|
| Stock-Based Compensation | 49.79 | 54.82 | 46.84 | 35.74 | 23.15 | 0.62 | Upgrade
|
| Other Operating Activities | -25.61 | -0.97 | -1.08 | -9.88 | -0.69 | -0.72 | Upgrade
|
| Change in Accounts Receivable | - | - | - | - | - | 0.78 | Upgrade
|
| Change in Accounts Payable | -5.06 | 10.92 | 15.53 | 13.96 | 14.31 | 7.12 | Upgrade
|
| Change in Other Net Operating Assets | 5.87 | -5.06 | -2.28 | 2.64 | -6.46 | -1.39 | Upgrade
|
| Operating Cash Flow | -171.76 | -207.82 | -163.75 | -154.09 | -86.83 | -39.14 | Upgrade
|
| Capital Expenditures | -0.39 | -0.58 | -2.55 | -6.11 | -0.76 | -0.35 | Upgrade
|
| Divestitures | - | - | - | -14.32 | - | - | Upgrade
|
| Investment in Securities | 102.55 | -43.88 | -111.63 | 2.31 | -284.07 | - | Upgrade
|
| Investing Cash Flow | 102.22 | -44.46 | -114.18 | -18.12 | -284.83 | -0.35 | Upgrade
|
| Issuance of Common Stock | 0.35 | 237.3 | 261.04 | 179.67 | 327.79 | - | Upgrade
|
| Repurchase of Common Stock | -0.24 | - | - | -1.15 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | - | 18.42 | -0.05 | Upgrade
|
| Financing Cash Flow | 0.11 | 237.3 | 261.04 | 178.52 | 360.44 | 81.83 | Upgrade
|
| Net Cash Flow | -69.43 | -14.98 | -16.89 | 6.31 | -11.22 | 42.34 | Upgrade
|
| Free Cash Flow | -172.15 | -208.41 | -166.3 | -160.2 | -87.58 | -39.5 | Upgrade
|
| Free Cash Flow Margin | -424.44% | - | - | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -2.43 | -3.19 | -3.15 | -3.75 | -3.12 | -7.06 | Upgrade
|
| Cash Income Tax Paid | 0.14 | 0.14 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Levered Free Cash Flow | -81.91 | -86.97 | -88.02 | -89.16 | -43.06 | -21.12 | Upgrade
|
| Unlevered Free Cash Flow | -81.91 | -86.97 | -88.02 | -89.16 | -43.06 | -21.12 | Upgrade
|
| Change in Net Working Capital | 1.82 | -13.02 | -8.32 | -10.51 | -8.63 | -7.79 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.